Costs and Clinical Consequences of Compliance with COPD GOLD Recommendations or National Guidelines Compared with Current Clinical Practice in Belgium, Germany, Sweden, and the United States
Sanjay Sethi,1 Antony Wright,2 Elisabeth Sophia Hartgers-Gubbels,3 Marlene Hechtner,3 Brendan Clark,4 Ciara Wright,2 Sue Langham,2 Roland Buhl5 1Pulmonary/Critical Care/Sleep Medicine, University at Buffalo, State University of New York, Buffalo, NY, USA; 2Maverex Ltd., Newcastle Upon Tyne, NE6 2HL, UK; 3Boehringer Ingelheim GmbH, Ingelheim Am Rhein, Germany; 4Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA; 5Pulmonary Department, Mainz University Hospital, Mainz, GermanyCorrespondence: Antony Wright, Maverex Ltd, Newcastle Upon Tyne, NE6 2HL, UK, Tel +44 (0) 161 4646838, Email... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Original Research |
Erscheinungsdatum: | 2022 |
Verlag/Hrsg.: |
Dove Press
|
Schlagwörter: | International Journal of Chronic Obstructive Pulmonary Disease |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28946269 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://www.dovepress.com/costs-and-clinical-consequences-of-compliance-with-copd-gold-recommend-peer-reviewed-fulltext-article-COPD |